Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Vascular Pharmacology
  4. Volume 23, Issue 1
  5. Article
Volume 23, Issue 1
  • ISSN: 1570-1611
  • E-ISSN: 1875-6212
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

There is no abstract available.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cvp/10.2174/0115701611357349240925071626
2024-09-26
2025-05-31

  • From This Site

    /content/journals/cvp/10.2174/0115701611357349240925071626
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cvp/23/1/CVP-23-1-03.html?itemId=/content/journals/cvp/10.2174/0115701611357349240925071626&mimeType=html&fmt=ahah

References

  1. PoredošP. SchernthanerG.H. BlincA. MikhailidisD.P. AntignaniP.L. AnagnostisP.G. JensterleM. StudenK.B. ŠabovićM. JezovnikM.K. Endocrine disorders and peripheral arterial disease: A series of reviews.Curr. Vasc. Pharmacol.202321314714810.2174/157016112166623051614131937194233
     [Google Scholar]
  2. BlincA. SchernthanerG.H. PoredošP. AnagnostisP. JensterleM. StudenK.B. AntignaniP.L. MikhailidisD.P. ŠabovićM. Testosterone and peripheral arterial disease.Curr. Vasc. Pharmacol.202321529730310.2174/157016112166623080914302337559242
     [Google Scholar]
  3. AnagnostisP. MikhailidisD.P. BlincA. JensterleM. JežovnikM.K. SchernthanerG.H. AntignaniP.L. StudenK.B. ŠabovićM. PoredosP. The effect of menopause and menopausal hormone therapy on the risk of peripheral artery disease.Curr. Vasc. Pharmacol.202321529329610.2174/011570161126334523091912290737779405
     [Google Scholar]
  4. JanezA. HermanR. PoredosP. MikhailidisD.P. BlincA. SabovicM. StudenK.B. JezovnikM.K. SchernthanerG.H. AnagnostisP. AntignaniP.L. JensterleM. Cardiometabolic risk, peripheral arterial disease and cardiovascular events in polycystic ovary syndrome: Time to implement systematic screening and update the management.Curr. Vasc. Pharmacol.202321642443210.2174/011570161126914623092007330137779406
     [Google Scholar]
  5. StudenK.B. GaberscekS. ZaletelK. BlincA. SabovicM. SchernthanerG.H. AnagnostisP. AntignaniP.L. JensterleM. MikhailidisD.P. PoredosP. Thyroid disorders and peripheral arterial disease.Curr. Vasc. Pharmacol.2024221364010.2174/011570161127128423110506314837957913
     [Google Scholar]
  6. RH. AJ. DpM. PP. AB. MS. KB.S. GhS. PA. PlA. MJ. Growth hormone, atherosclerosis and peripheral arterial disease: Exploring the spectrum from acromegaly to growth hormone deficiency.Curr. Vasc. Pharmacol.2024221283510.2174/011570161126916223110604295637962050
     [Google Scholar]
  7. PoredosP. SchernthanerG.H. BlincA. Endocrine disorders and peripheral arterial disease – A series of reviews cushing syndrome-cortisol excess.Curr. Vasc. Pharmacol.202422423624110.2174/0115701611272145231106053914
     [Google Scholar]
  8. AntignaniP.L. JezovnikM.K. BlincA. MikhailidisD.P. AnagnostisP. SchernthanerG.H. JensterleM. StudenK.B. SabovicM. PoredosP. Hyperparathyroidism and peripheral arterial disease.Curr. Vasc. Pharmacol.2024222889410.2174/011570161128090523122704582638284694
     [Google Scholar]
  9. MelmedS. AuchusR.J. GoldfineA.B. Williams Textbook of Endocrinology.15th edElsevier2024
     [Google Scholar]
/content/journals/cvp/10.2174/0115701611357349240925071626
Loading

  • Article Type:     Editorial

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test